INVO (INVO Bioscience, Inc.) Bathi resik

Slow growth in demand for oocyte maturation systems is limiting business efficiency, coinciding with a transition to AI-driven lending services and a name change to Janover. The net operating profit of INVO Bioscience, Inc. (INVO) on this chart reflects revenue dynamics, where the current value is -0.01. Management aims to scale its own clinic network by implementing affordable infertility treatments through unique cultivation technologies.

Investors utilize this metric as a leading indicator of operational efficiency, assessing the business's ability to generate daily net cash flow. By analyzing the current profit level of INVO Bioscience, Inc. (INVO), calculated as the difference between total revenues and all expenses, one can confirm the commercial sustainability of INVO Bioscience, Inc. (INVO) through the implementation of innovative IVF systems in specialized clinics.